Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-like Peptide-1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT03182231
What this trial is testing

GLP1-imaging Before and After Bariatric Surgery

Who this might be right for
Diabetes Mellitus, Type 2Bariatric Surgery Candidate
Radboud University Medical Center 12
Not applicableLooking for participantsNCT07251803
What this trial is testing

GLP1 Fasting Status and Gastric Retention Using Gastric Ultrasound

Who this might be right for
Gastric Retention
Medical University of South Carolina 150
Testing effectiveness (Phase 2)Active Not RecruitingNCT07458269
What this trial is testing

Efficacy and Safety of Ribupatide (KAI-9531) Administered Once Weekly in Participants Living With Obesity Who Do Not Have Diabetes

Who this might be right for
Obesity
Kailera 264
Not applicableStudy completedNCT07001553
What this trial is testing

Understanding Acute Dietary Changes After GLP-1 Agonist Treatment: The GLaD Feasibility Study

Who this might be right for
ObesityType 2 Diabetes Mellitus (T2DM)
Australian Catholic University 37
Testing effectiveness (Phase 2)Ended earlyNCT00609154
What this trial is testing

Effect of GLP-1 on Insulin Biosynthesis and Turnover Rates

Who this might be right for
Type 2 Diabetes
Albert Einstein College of Medicine 20
Post-approval studies (Phase 4)Looking for participantsNCT07017270
What this trial is testing

Glucagon-like-peptide-1 Receptor Agonists in Patients Receiving Maintenance Dialysis

Who this might be right for
Kidney Disease, ChronicDiabetesDialysis+1 more
Unity Health Toronto 100
Early research (Phase 1)Study completedNCT05444569
What this trial is testing

LY3537021 in Healthy Participants

Who this might be right for
Healthy
Eli Lilly and Company 47
Early research (Phase 1)Study completedNCT01088841
What this trial is testing

Sweet Taste Receptors and the Secretion of Glucagon-like Peptide-1 and Peptide YY

Who this might be right for
Appetite and General Nutritional DisordersHormone Replacement
University Hospital, Basel, Switzerland 16
Large-scale testing (Phase 3)Looking for participantsNCT05305794
What this trial is testing

Effect of Weekly GLP1 Agonist Treatment in "Double Diabetes"

Who this might be right for
Double Diabetes
Centre Hospitalier Universitaire Dijon 76
Not applicableStudy completedNCT03829800
What this trial is testing

Formulas for Diabetes With Sucromalt & Isomaltulose on Glycemic Index, Hormones & Subjective Appetite in Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Universidad del Zulia 23
Not applicableStudy completedNCT01656057
What this trial is testing

The Impact of Gall Bladder Emptying and Bile Acids on the Human GLP-1-secretion

Who this might be right for
To Assess the Impact of Bile Acids on Human Glukagon-like-peptide-1 Secretion
Filip Krag Knop 10
Not applicableStudy completedNCT06120556
What this trial is testing

Efficacy of Glucagon-like Peptide-1 Receptor Agonists According to Type 2 Diabetes Subtypes

Who this might be right for
Diabetes Mellitus, Type 2
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari 130
Not applicableStudy completedNCT02921906
What this trial is testing

Effect of Food Composition on Postprandial Insulin Secretion in Neonatal Diabetes

Who this might be right for
Neonatal Diabetes
Royal Devon and Exeter NHS Foundation Trust 16
Not applicableUnknownNCT06344247
What this trial is testing

Comparison of the Efficacy and Safety of SGLT2i and GLP-1 Receptor Agonists in Obese Patients With Kidney Disease

Who this might be right for
ObesityChronic Kidney Diseases
RenJi Hospital 48
Early research (Phase 1)Study completedNCT06996886
What this trial is testing

A Study in Healthy Participants to Investigate Relative Bioavailability of AZD5004 in Three Solid Oral Formulations

Who this might be right for
Healthy Participants
AstraZeneca 16
Not applicableNot Yet RecruitingNCT07770906
What this trial is testing

Effect of GLP-1 Receptor Agonists on Periodontal Health and Response to Nonsurgical Periodontal Therapy

Who this might be right for
Periodontal DiseaseObesity & Overweight
Cukurova University 40
Early research (Phase 1)Not Yet RecruitingNCT06608329
What this trial is testing

A Relative Bioavailability and Food Effect Study of HDM1002 in Healthy Subjects

Who this might be right for
Healthy Adult Subject
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 33
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07830329
What this trial is testing

Efficacy and Safety of Olatorepatide Versus Placebo in Adults With Moderate to Severe Hidradenitis Suppurativa Living With Overweight or Obesity

Who this might be right for
Hidradenitis Suppurativa
Regeneron Pharmaceuticals 300
Not applicableStudy completedNCT01988545
What this trial is testing

GLP-1's Effect on Cardiac Parameters and Mesenteric Blood Flow

Who this might be right for
Healthy
Zealand University Hospital 8
Not applicableStudy completedNCT05037045
What this trial is testing

Effect of Gene Polymorphisms on GLP-1 Receptor Agonists Response in Patients With T2DM

Who this might be right for
Type 2 Diabetes Mellitus
The Affiliated Hospital of Xuzhou Medical University 338
Next Page